Mediastinal Cancer

  • Neil AndersonEmail author


Mediastinal Cancer: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with core data required to make corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM8 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the more common non-carcinoma malignancies that are encountered at this site in diagnostic practice.


Thymoma Thymic carcinoma TNM8 Masaoka-Koga staging Immunochemistry 


  1. Anastasiadis K, Ratatunga C. The thymus gland: diagnosis and surgical management. 1st ed: Springer; 2007.Google Scholar
  2. Burke A, Jeudy J Jr, Virmani R. Cardiac tumours; an update. Heart. 2008;94:117–23.CrossRefGoogle Scholar
  3. Den Bakker MA, Oosterhuis JW. Tumours and tumour-like conditions of the thymus other than thymoma: a practical approach. Histopathology. 2009;54:69–89.CrossRefGoogle Scholar
  4. Detterbeck F. International thymic malignancies interest group: a way forward. J Thorac Oncol. 2010;5:S365–70.CrossRefGoogle Scholar
  5. Detterbeck FC, Nicholson AG, Kondo K, Van Schil P, Moran C. The Masaoka-Koga stage classification of thymic malignancies: clarification and definition of terms. J Thorac Oncol. 2011a;6:S1710–6.CrossRefGoogle Scholar
  6. Detterbeck FC, Moran C, Huang J, Suster S, Walsh G, Kaiser L, et al. Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy. J Thorac Oncol. 2011b;6:S1730–8.CrossRefGoogle Scholar
  7. Marx A, Chan JK, Coindre JM, Detterbeck F, Girard N, Harris NL, Jaffe ES, Kurrer MO, Marom EM, Moreira AL, Mukai K, Orazi A, Ströbel P. The 2015 World Health Organization classification of tumors of the thymus: continuity and changes. J Thorac Oncol. 2015;10:1383–95.CrossRefGoogle Scholar
  8. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485–92.CrossRefGoogle Scholar
  9. Muller-Hermelink HK, Marx A, Kircher TH. Advances in the diagnosis and classification of thymic epithelial tumours. In: Anthony PP, MacSween RNM, editors. Recent advances in histopathology, vol. 16. Edinburgh: Churchill Livingstone; 1994. p. 49–72.Google Scholar
  10. Nicholson AG, Detterbeck FC, Marino M, Kim J, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, Filosso PL, Giaccone G, Huang J, Kondo K, Lucchi M, Marom EM, Okumura M, Ruffini E, Van Schil P. The IASLC/ITMIG thymic epithelial tumors staging project: proposals for the T component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014;9:S73–80.Google Scholar
  11. Salter DM. Pulmonary and thoracic sarcomas. Curr Diagn Pathol. 2006;12:409–17.CrossRefGoogle Scholar
  12. The Royal College of Pathologists. Dataset for the histological reporting of thymic epithelial tumours; 2017.
  13. Travis WD, Brambilla E, Burke AP, et al. WHO classification of tumours of the lung, pleura, thymus and heart. Lyon: IARC; 2015.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Institute of PathologyRoyal Victoria HospitalBelfastUK

Personalised recommendations